Highly pathogenic avian influenza A(H5N1) mutants transmissible by air are susceptible to human and animal neutralizing antibodies

Journal of Infectious Diseases

Volumn 208, Issue 8, 2013, Pages 1315-1319

  Du, Lanying ^a   Li, Ye ^a   Zhao, Guangyu ^b   Wang, Lili ^a   Zou, Peng ^a   Lu, Lu ^c   Zhou, Yusen ^b   Jiang, Shibo ^a,c,d  

^a NEW YORK BLOOD CENTER   (United States)

^b BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

^c BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^d FUDAN UNIVERSITY   (China)

Author keywords

Air transmissibility; H5N1 influenza virus; Neutralizing antibodies; Patient serum specimens

Indexed keywords

AVIAN INFLUENZA VACCINE; HA1 PROTEIN; INFLUENZA VIRUS HEMAGGLUTININ; MONOCLONAL ANTIBODY; NEUTRALIZING ANTIBODY; UNCLASSIFIED DRUG;

AIRBORNE INFECTION; AMINO ACID SEQUENCE; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ARTICLE; AVIAN INFLUENZA; AVIAN INFLUENZA VIRUS; BLOOD SAMPLING; CROSS REACTION; HUMAN; IMMUNIZATION; INFLUENZA A (H5N1); INFLUENZA VIRUS A H5N1; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PANDEMIC INFLUENZA; PRIORITY JOURNAL; VIRUS MUTANT; VIRUS STRAIN; VIRUS TRANSMISSION; WILD TYPE;

AIR-TRANSMISSIBILITY; H5N1 INFLUENZA VIRUS; NEUTRALIZING ANTIBODIES; PATIENT SERUM SPECIMENS;

ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; HUMANS; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; MICE; NEUTRALIZATION TESTS;

EID: 84885074330     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jit323     Document Type: Article

References (15)

1. World Health Organization. Cumulative number of confirmed human cases for avian influenza A(H5N1) reported to WHO, 2003-2013. July 2013. http://www.who.int/influenza/human-animal-interface/ EN-GIP- 20130705CumulativeNumberH5N1cases-2.pdf.
2. Imai M, Watanabe T, Hatta M, et al. Experimental adaptation of an influenza H5 HA confers respiratory droplet transmission to a reassortant H5 HA/H1N1 virus in ferrets. Nature 2012; 486:420-8.
3. Russell CA, Fonville JM, Brown AE, et al. The potential for respiratory droplet-transmissible A/H5N1 influenza virus to evolve in a mammalian host. Science 2012; 336:1541-7.
4. Herfst S, Schrauwen EJ, Linster M, et al. Airborne transmission of influenza A/H5N1 virus between ferrets. Science 2012; 336:1534-41.
5. Berns KI, Casadevall A, Cohen ML, et al. Public health and biosecurity. Adaptations of avian flu virus are a cause for concern. Science 2012; 335:660-1.
6. Starbuck ES. Mutant flu: Preparing for a pandemic. Nature 2012; 482: 470.
7. Osterholm MT, Kelley NS. Mammalian-transmissible H5N1 influenza: Facts and perspective. MBio 2012; 3:e00045-12.
8. Rath J. Mutant flu: Assessing biosecurity risks. Nature 2012; 482:470.
9. Lipsitch M, Bloom BR. Rethinking biosafety in research on potential pandemic pathogens. MBio 2012; 3:e00360-e00412.
10. Du L, Jin L, Zhao G, et al. Identification and structural characterization of a broadly neutralizing antibody targeting a novel conserved epitope on the influenza virus H5N1 hemagglutinin. J Virol 2013; 87: 2215-25.
11. Du L, Leung VH, Zhang X, et al. A recombinant vaccine of H5N1 HA1 fused with foldon and human IgG Fc induced complete crossclade protection against divergent H5N1 viruses. PLoS One 2011; 6: E16555.
12. Du L, Zhao G, Zhang X, et al. Development of a safe and convenient neutralization assay for rapid screening of influenza HA-specific neutralizing monoclonal antibodies. Biochem Biophys Res Commun 2010; 397:580-5.
13. Du L, Zhao G, Sun S, et al. A critical HA1 neutralizing domain of H5N1 influenza in an optimal conformation induces strong cross-protection. PLoS One 2013; 8:e53568.
14. WangW, Lu B, Zhou H, et al. Glycosylation at 158N of the hemagglutinin protein and receptor binding specificity synergistically affect the antigenicity and immunogenicity of a live attenuated H5N1 A/Vietnam/1203/2004 vaccine virus in ferrets. J Virol 2010; 84:6570-7.
15. Webster RG. Mammalian-transmissible H5N1 influenza: The dilemma of dual-use research. MBio 2012; 3:e00005-12.